These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 484623)

  • 41. Urinary oestriol excretion in pregnancies complicated by suspected retarded intrauterine growth, toxaemia or essential hypertension.
    Michie EA
    J Obstet Gynaecol Br Commonw; 1967 Dec; 74(6):896-901. PubMed ID: 6066466
    [No Abstract]   [Full Text] [Related]  

  • 42. The incidence and significance of low oestriol excretion in an obstetric population.
    Beischer NA; Bhargava VL; Brown JB; Smith MA
    J Obstet Gynaecol Br Commonw; 1968 Oct; 75(10):1024-33. PubMed ID: 5684416
    [No Abstract]   [Full Text] [Related]  

  • 43. [Pregnancies of high fetal risk. Use of urine estriol in the management of pregnancy toxemias].
    Gormaz G; Barnafi L; Espinoza J; Manubens F
    Rev Chil Obstet Ginecol; 1974; 39(6):227-38. PubMed ID: 4469929
    [No Abstract]   [Full Text] [Related]  

  • 44. Toxemia of pregnancy: assessment of fetal distress by urinary estriol and circulating human placental lactogen and alpha-fetoprotein levels.
    Garoff L; Seppälä M
    Am J Obstet Gynecol; 1976 Dec; 126(8):1027-33. PubMed ID: 63245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Congenital malformations, abnormal glucose tolerance, and estriol excretion in pregnancy.
    Drew JH; Abell DA; Beischer NA
    Obstet Gynecol; 1978 Feb; 51(2):129-32. PubMed ID: 564006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low oestriol excretion: incidence, significance and treatment in an obstetric population.
    Beischer NA
    Med J Aust; 1975 Sep; 2(10):379-81. PubMed ID: 1186540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Plasma estriol in the hypertension of pregnancy].
    Herrera M; Valderrama O; Bianchi R; Devoto L; Castro O
    Rev Chil Obstet Ginecol; 1984; 49(6):442-53. PubMed ID: 6545832
    [No Abstract]   [Full Text] [Related]  

  • 48. The recurrence rate and significance of low oestriol excretion in successive pregnancies.
    Oats JJ; Beischer NA
    Br J Obstet Gynaecol; 1979 Jan; 86(1):15-8. PubMed ID: 760760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A study on the relation among oxytocin challenge test, maternal serum estriol level and placental change (author's transl)].
    Sawazumi K; Tonari M; Sakai K
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 May; 34(5):589-93. PubMed ID: 7086240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estriol excretion in abnormal pregnancy.
    Heys RF; Scott JS; Oakey RE; Stitch SR
    Obstet Gynecol; 1969 Mar; 33(3):390-6. PubMed ID: 5776089
    [No Abstract]   [Full Text] [Related]  

  • 51. Relationship between elvated blood pressure and urinary estriols during pregnancy.
    MacLeod SC; Mitton DM; Avery CR
    Am J Obstet Gynecol; 1971 Feb; 109(3):375-82. PubMed ID: 5552620
    [No Abstract]   [Full Text] [Related]  

  • 52. The relative usefulness of methods of assessing placental function.
    Watney PJ; Hallum J; Ladell D; Scott P
    J Obstet Gynaecol Br Commonw; 1970 Apr; 77(4):301-11. PubMed ID: 5427292
    [No Abstract]   [Full Text] [Related]  

  • 53. Evaluation of the contraction stress test before 33 weeks' gestation.
    Gabbe SG; Freeman RD; Goebelsmann U
    Obstet Gynecol; 1978 Dec; 52(6):649-52. PubMed ID: 733130
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estriol determinations in gestational diabetes.
    Lockwood GF; Newman RL
    Obstet Gynecol; 1974 Nov; 44(5):642-5. PubMed ID: 4608396
    [No Abstract]   [Full Text] [Related]  

  • 55. Leukocyte alkaline phosphatase and urinary estriol in the evaluation of placental functions.
    Diamant YZ; Sadovsky E; Polishuk WZ
    Obstet Gynecol; 1974 Feb; 43(2):186-90. PubMed ID: 4810229
    [No Abstract]   [Full Text] [Related]  

  • 56. Correlation between morning urine estriol concentration and 24-hour estriol excretion.
    Biezenski JJ; Millner SN
    Obstet Gynecol; 1976 Dec; 48(6):678-81. PubMed ID: 995337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estriol determinations in the management of high-risk pregnancies.
    Magendantz HG; Klausner D; Ryan KJ; Yen SS
    Obstet Gynecol; 1968 Nov; 32(5):610-9. PubMed ID: 5742475
    [No Abstract]   [Full Text] [Related]  

  • 58. Oxytocin challenge test in monitoring high-risk pregnancies.
    Cooper JM; Soffronoff EC; Bolognese RJ
    Obstet Gynecol; 1975 Jan; 45(1):27-33. PubMed ID: 1110815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An 18-month follow-up study of growth-retarded neonates. Relation to biochemical tests of placental function in late pregnancy and neurobehavioural condition in the newborn period.
    Leijon I; Billström G; Lind I
    Early Hum Dev; 1980 Sep; 4(3):271-85. PubMed ID: 6158397
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The use of urinary estriol excretion studies in the assessment of the high-risk pregnancy.
    Greene JW; Beargie RA
    Pediatr Clin North Am; 1970 Feb; 17(1):43-8. PubMed ID: 5419108
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.